Introduction
Can a company be prosecuted for an offence requiring mens rea when the prosecution has not identified or arraigned the particular employee or officer through whom the alleged criminal conduct was committed?
The Supreme Court of India has answered an important part of this question in Sanofi India Ltd. v. Central Bureau of Investigation, 2026 INSC 957. The judgment, delivered on 7 September 2026 by Justice J.B. Pardiwala and Justice Manoj Misra, examines corporate criminal liability, the attribution of mens rea to companies and the circumstances in which criminal proceedings against a corporation may be quashed under Section 482 of the Code of Criminal Procedure, 1973.
The Court held that identification and arraignment of a particular natural person are not, by themselves, prerequisites for maintaining a criminal prosecution against a corporation at the Section 482 CrPC stage. However, this does not mean that a company can be prosecuted on completely bald allegations. The allegations must prima facie disclose that natural persons acted on behalf of the corporation, that their conduct is referable to the offence and that the surrounding circumstances do not make the existence of the requisite mens rea inherently improbable.
The judgment is particularly significant because the Supreme Court did more than decide the immediate quashing issue. It filled what it identified as a doctrinal gap in Indian law by setting out a three-stage framework for attributing the mens rea of a natural person to a corporation.
Case Details
| Particular | Details |
|---|---|
| Case Name | Sanofi India Ltd. v. Central Bureau of Investigation |
| Court | Supreme Court of India |
| Citation | 2026 INSC 957 |
| Case Number | Criminal Appeal No. 4250 of 2026 |
| Arising From | SLP (Criminal) No. 3597 of 2019 |
| Judgment Date | 7 September 2026 |
| Bench | Justice J.B. Pardiwala and Justice Manoj Misra |
| Appellant | Sanofi India Ltd. |
| Respondent | Central Bureau of Investigation |
| Impugned Order | Karnataka High Court judgment dated 15 February 2019 |
| Principal Provision Considered | Section 482 CrPC |
| Principal Legal Area | Corporate criminal liability, mens rea, attribution and quashing of criminal proceedings |
The appeal arose from the Karnataka High Court’s refusal to quash proceedings in Special C.C. No. 226/2017 pending before the XLVI Additional City Civil and Sessions Judge and Special Judge for CBI Cases, Bengaluru.
Facts and Procedural History
Sanofi India Ltd. is a public limited company primarily engaged in manufacturing pharmaceutical products. It supplied pharmaceutical products pursuant to tender processes for the Rare Materials Project of the Bhabha Atomic Research Centre (BARC) during the relevant years.
The CBI registered FIR No. RC.17(A)/2015 in connection with allegations concerning procurement of medicines for BARC. The prosecution alleged that Dr. P. Anand, a Scientific Officer (Medical) at BARC, had entered into a criminal conspiracy with pharmaceutical companies for procurement of medicines at inflated rates and in quantities exceeding requirements.
According to the chargesheet, Dr. Anand allegedly:
- misclassified certain items as proprietary so that they could be procured from Sanofi despite lower bids from competing companies;
- omitted competing bidders from the tender process; or
- failed to place orders with the lowest bidder after quotations were received.
The prosecution alleged that this resulted in a wrongful loss to BARC of ₹3,53,361, accompanied by a corresponding wrongful gain.
The CBI also alleged that Dr. Anand received ₹42,750 as illegal gratification from Sanofi under various pretexts and that Sanofi had abetted the commission of the offence under Section 11 of the Prevention of Corruption Act, 1988.
The chargesheet invoked Section 120B read with Section 420 IPC and Sections 11, 12 and 13(2) read with Section 13(1)(b) and (d) of the Prevention of Corruption Act, 1988. Significantly, no employee or official of Sanofi was arraigned as an accused alongside the company.
The Trial Court took cognizance and issued process against Sanofi and Dr. Anand. Sanofi then approached the Karnataka High Court under Section 482 CrPC seeking quashing of the criminal proceedings.
The High Court declined to interfere. It relied, among other things, on Iridium India Telecom Ltd. v. Motorola Inc., holding that a corporate entity can be prosecuted for offences requiring mens rea and that the allegations required a trial rather than threshold quashing.
Sanofi therefore approached the Supreme Court.
Legal Issues Before the Supreme Court
The central question was:
Whether criminal proceedings against a corporation should be quashed under Section 482 CrPC merely because no natural person had been identified and arraigned alongside the corporation.
The question required the Court to examine several connected issues:
- Whether corporations can incur criminal liability for offences requiring mens rea.
- How mens rea can legally be attributed to an artificial legal entity.
- Whether identification of the particular natural person is mandatory at the threshold stage.
- Whether arraignment of such natural person is a prerequisite for prosecution of the company.
- Whether the “directing mind and will” or “alter ego” doctrine supplies the complete answer under Indian law.
- How decisions concerning statutory vicarious liability, particularly Aneeta Hada, should be distinguished from cases involving direct corporate liability.
Arguments of Sanofi India Ltd.
Sanofi argued that where an offence requires proof of mens rea, the prosecution must identify the company’s alter ego or governing mind whose conduct and state of mind can legally be attributed to the company.
Relying upon the identification principle and the English doctrine of the “directing mind and will,” the appellant argued that the conduct and mental state of key corporate personnel are treated as those of the corporation. According to Sanofi, unless such a person was identified and arraigned, there was no proper basis for attributing either mens rea or the overt conduct necessary to establish criminal conspiracy to the company.
The appellant therefore contended that the High Court had overlooked the identification principle and failed to examine whether there was material against a specific individual constituting the governing mind or alter ego of Sanofi.
Arguments of the CBI
The CBI opposed the appeal.
It relied on Iridium India and Standard Chartered Bank v. Directorate of Enforcement, contending that corporate prosecution could proceed even without separately identifying or arraigning every employee involved in the alleged conduct.
The CBI also submitted that the available oral and documentary material prima facie demonstrated that Sanofi had received undue favour from Dr. Anand and, in reciprocity, had paid him a bribe. According to the CBI, the material disclosed a conspiracy between Sanofi and Dr. Anand sufficient to justify continuation of the proceedings.
Detailed Court Analysis
Corporate Criminal Liability: The Foundational Problem
The Supreme Court began with the conceptual difficulty surrounding corporate criminal liability.
A corporation is a separate legal person, but it is also an artificial entity. Criminal law traditionally focuses on the act and mental state of the accused. The difficulty therefore arises when the accused is a corporation: how can an abstract legal entity possess the guilty mind required for an offence?
The Court explained that criminal responsibility ordinarily consists of actus reus and mens rea. A corporation acts through natural persons, making attribution the legal mechanism through which the conduct and mental state of human beings may become, in law, the conduct and mental state of the corporation.
The Court therefore separated two questions:
- Whether a corporation can possess mens rea; and
- How the mens rea of a natural person can be attributed to the corporation.
The first question had substantially been answered in favour of corporate criminal liability by earlier decisions. The second question, however, required a more developed framework.
Iridium India: The “Whether” Question Was Not the “How” Question
The Supreme Court carefully revisited Iridium India Telecom Ltd. v. Motorola Inc.
Iridium India had established that corporations cannot claim immunity from criminal prosecution merely because an offence requires mens rea. However, the present Court clarified that Iridium India principally answered the “whether” question—whether corporations can be criminally liable for mens rea offences.
It did not comprehensively establish the “how” question—how a particular natural person’s mens rea is to be attributed to the corporation under Indian law.
This distinction became the foundation for the new attribution framework.
Corporate Criminal Liability and Mens Rea
The Court reaffirmed that a corporation may be prosecuted for offences requiring proof of mens rea. Earlier decisions, including Velliappa Textiles, Standard Chartered Bank and Iridium India, had developed the law concerning corporate prosecution and the difficulty created by offences carrying imprisonment or requiring a guilty mind.
But the Court stressed an important proposition:
Corporate mens rea cannot be constructed by combining fragments of the mental states of several individuals.
The requisite mens rea must be found in full within at least one natural person before it can be attributed to the corporation. There may be more than one such person, but the prosecution cannot simply aggregate partial states of mind belonging to different individuals to manufacture a corporate guilty mind.
This provides an important safeguard for corporations while simultaneously recognising their potential criminal responsibility.
The Supreme Court’s New Three-Stage Attribution Framework
The most significant contribution of Sanofi India Ltd. v. CBI is the three-stage attribution framework.
The Court drew guidance from developments in English law, including the identification doctrine, the attribution rules developed in Meridian Global Funds Management Asia Ltd. v. Securities Commission, and the sequential approach developed in the Barclays cases.
Stage One: Corporate Constitution and Company Law
The first question is whether the corporation’s constitutional documents or a rule implied by company law vest the concerned natural person with the power to perform the relevant act.
In other words, the Court first looks internally at the company’s constitutional structure and the authority legally attached to the individual.
Stage Two: Delegated Authority
If attribution cannot be established at the first stage, the Court asks whether the relevant power was delegated to the person, expressly or impliedly, with sufficient discretion and independence in carrying out the act.
Thus, mere employment is not enough. The nature and extent of authority exercised by the individual matter.
Stage Three: Special Rule Based on Statutory Purpose
If attribution cannot be established through the first two stages, the Court moves to the third stage.
Here, the court considers the purpose of the statute and determines whether a special rule of attribution needs to be fashioned.
Where the statutory purpose is narrow, the question is whether the purpose considered in the abstract requires such a rule. Where the statutory purpose is broad, the court considers the statutory purpose together with the facts and circumstances of the case. If a special rule is warranted, the next question is whether the person concerned falls within it.
The framework is therefore hierarchical and sequential. The court moves from one stage to the next only when attribution cannot be established at the preceding stage.
Important Qualifications to the Framework
The Court made several important clarifications.
First, attribution is transaction-specific. The exercise is not an abstract search for a corporation’s permanent “directing mind.”
Second, the framework principally applies to offences framed with natural persons in mind and requiring proof of mens rea.
Third, where a statute itself supplies the rule of attribution, there is no need to invoke the framework.
Fourth, where legislation creates a specific form of vicarious liability, the statutory scheme governs.
Fifth, strict or absolute liability offences operate on a different footing because attribution may not be required in the same manner.
Finally, attribution operates in one direction—from the natural person to the corporation. It does not automatically determine the criminal liability of the natural person, whose liability continues to be governed by ordinary criminal-law principles.
“Directing Mind and Will” Is Not a Standalone Test
A significant aspect of the judgment is the Court’s treatment of the expression “directing mind and will.”
The judgment traces the concept through English authorities such as Lennard’s Carrying Co. v. Asiatic Petroleum Co. and Tesco Supermarkets Ltd. v. Nattrass.
However, the Supreme Court’s framework does not create a rigid rule that only directors, managing directors or persons holding a particular corporate designation can supply the relevant state of mind.
Indeed, the Court expressly observed that the framework does not recognise a standalone, status-based rule under which a person’s corporate title alone is sufficient for attribution. Authority and the nature of the person’s acts remain important.
This is why the Court’s analysis extends beyond formal directors or “persons in charge” to natural persons generally.
Can Proceedings Be Quashed Merely Because No Natural Person Was Identified?
The Supreme Court answered No.
Section 482 CrPC gives High Courts an exceptional inherent power. It must be exercised cautiously, and the core enquiry is whether the allegations, taken at face value, disclose the commission of an offence.
The High Court cannot conduct a mini-trial or assess whether the prosecution will ultimately be able to prove its case.
The Court therefore rejected the proposition that non-identification of a natural person automatically means that the allegations against the corporation fail.
The chargesheet must disclose the corporation’s own alleged role. It does not necessarily have to identify, at the threshold, the precise individual through whom every act was performed.
The Threshold Test for Corporate Prosecution
At the Section 482 stage, the allegations should at least prima facie reveal:
- that one or more natural persons acted on behalf of the corporation;
- that their actions are referable to the offence in question; and
- that the surrounding circumstances do not make the existence of the required mens rea patently absurd or inherently improbable.
The enquiry is broad rather than microscopic.
Thus, the Court retained the possibility of quashing a corporate prosecution where the allegations are genuinely bald or fail to disclose an offence. What the Court rejected was an automatic quashing rule based solely on the absence of a named natural person.
Identification and Arraignment: Why Aneeta Hada Was Distinguished
Sanofi relied on Aneeta Hada v. Godfather Travels & Tours Pvt. Ltd. and Hindustan Unilever Ltd. v. State of M.P.
The Supreme Court explained that those cases concerned statutory vicarious liability schemes.
For example, Section 141 of the Negotiable Instruments Act creates a statutory mechanism under which persons may incur vicarious liability for an offence committed by a company. In that context, arraignment of the company is a statutory condition precedent.
The Court held that Aneeta Hada cannot be transformed into a general proposition that a natural person must always be arraigned before a corporation can be prosecuted.
The present case was different because the liability under consideration was not vicarious liability imposed through a statutory fiction. Instead, the attribution framework potentially fixes the corporation with direct criminal liability, because the relevant act and mental state are treated as those of the corporation once the framework is satisfied.
Application of the Framework to Sanofi
Applying the threshold test, the Supreme Court found that the allegations and materials were sufficient to allow the prosecution to proceed.
The chargesheet indicated that natural persons had acted on behalf of Sanofi in relation to the alleged offences. The surrounding circumstances also gave rise, at least prima facie, to the possibility that the relevant acts were undertaken with the requisite mens rea.
That was enough at the Section 482 stage.
The Court emphasised that questions concerning exactly whose acts and state of mind should ultimately be attributed to the corporation may require a detailed examination of evidence and factual circumstances at trial.
Important Statutory Provisions
Section 482, Code of Criminal Procedure, 1973
Section 482 preserves the High Court’s inherent powers to prevent abuse of the process of court and secure the ends of justice.
In Sanofi India, the Supreme Court stressed that the provision is not ordinarily a vehicle for conducting a mini-trial. The initial question is whether the allegations, taken at face value, disclose an offence.
Section 120B, Indian Penal Code, 1860
Section 120B concerns punishment for criminal conspiracy. The prosecution invoked Section 120B read with Section 420 IPC against the accused.
Section 420, Indian Penal Code, 1860
Section 420 concerns cheating and dishonestly inducing delivery of property.
Sections 11, 12 and 13, Prevention of Corruption Act, 1988
The prosecution also invoked provisions of the Prevention of Corruption Act concerning illegal gratification, abetment and criminal misconduct, including Section 13(1)(b) and (d), read with Section 13(2), as applicable to the allegations in the case.
The judgment itself also notes that neither the IPC nor the Bharatiya Nyaya Sanhita, 2023 provides a comprehensive statutory answer to the question of how corporate mens rea is to be attributed.
Important Precedents
| Precedent | Significance in Sanofi India |
|---|---|
| Iridium India Telecom Ltd. v. Motorola Inc. | Established that corporations can be prosecuted for offences requiring mens rea. |
| Standard Chartered Bank v. Directorate of Enforcement | Addressed prosecution of corporate entities and mandatory imprisonment issues. |
| Velliappa Textiles Ltd. v. Union of India | Considered corporate liability for mens rea offences; later developments clarified the mandatory-imprisonment issue. |
| Tesco Supermarkets Ltd. v. Nattrass | Important English authority on the identification principle and corporate attribution. |
| Meridian Global Funds Management Asia Ltd. v. Securities Commission | Contributed to the development of rules of corporate attribution. |
| Aneeta Hada v. Godfather Travels & Tours Pvt. Ltd. | Distinguished because it concerned statutory vicarious liability under Section 141 of the Negotiable Instruments Act. |
| Hindustan Unilever Ltd. v. State of M.P. | Similarly concerned a statutory scheme requiring company arraignment. |
| State of Haryana v. Bhajan Lal | Relevant to principles governing quashing of criminal proceedings. |
| Neeharika Infrastructure Pvt. Ltd. v. State of Maharashtra | Reaffirmed caution in exercising Section 482 jurisdiction. |
| Sunil Bharti Mittal v. CBI | Relevant to principles concerning individual criminal liability in the corporate context. |
The Supreme Court’s treatment of Iridium India is particularly significant: the judgment clarifies that recognising corporate mens rea does not automatically resolve the separate question of attribution.
Ratio Decidendi
The ratio of Sanofi India Ltd. v. CBI may be summarised as follows:
A corporation may incur criminal liability for an offence requiring mens rea through attribution of the requisite mental state of a natural person to the corporation. At the Section 482 CrPC stage, identification and arraignment of that particular natural person are not, by themselves, mandatory preconditions for maintaining prosecution against the corporation.
However, the allegations must prima facie disclose that natural persons acted on behalf of the corporation, that their conduct is connected with the offence and that the surrounding circumstances make the existence of the requisite mens rea reasonably possible.
The Court further held that corporate mens rea must be found in full within at least one natural person; it cannot be manufactured by combining fragments of different individuals’ mental states.
Final Decision
The Supreme Court dismissed Sanofi India’s appeal.
It held that the High Court was not required to quash the proceedings merely because no natural person had been identified and arraigned alongside the company.
At the same time, the Supreme Court expressly limited its analysis concerning identification and arraignment to the exercise of Section 482 CrPC jurisdiction. It did not decide as a general proposition whether identification or arraignment might become necessary at some later stage of criminal proceedings.
The Court accordingly allowed the criminal proceedings to continue and directed the Registry to forward a copy of the judgment to all High Courts.
Practical Implications of the Judgment
For Companies
Companies cannot assume that prosecution will fail merely because the investigating agency has not named a particular employee as an accused. Corporate conduct and surrounding circumstances may be sufficient to cross the Section 482 threshold.
For Corporate Compliance Teams
The judgment highlights the importance of internal delegation, decision-making structures and documentation. The first two stages of the attribution framework focus heavily on authority and delegation within the corporation.
For Directors and Officers
Holding a particular corporate position does not automatically make a person’s conduct attributable to the company. Conversely, a person need not necessarily be a formal director for their acts and state of mind to become relevant to corporate attribution.
For Prosecuting Agencies
A prosecution should contain allegations showing the corporation’s own role rather than merely naming the company. The absence of a specifically named employee is not fatal, but a complete absence of allegations connecting natural-person conduct with the corporation may still justify quashing.
For Defence Lawyers
A Section 482 petition cannot rely solely on the argument that no natural person was arraigned. The stronger question is whether the allegations, even taken at face value, disclose the corporation’s role, the relevant conduct and the possibility of mens rea.
For Trial Courts
The attribution framework provides a structured method for addressing corporate mens rea while recognising that detailed attribution questions may ultimately depend on evidence at trial.
Key Takeaways
- A company can be prosecuted for offences requiring mens rea.
- Corporate mens rea exists through attribution from natural persons.
- The requisite mens rea must exist in full within at least one natural person.
- Partial mental states of multiple individuals cannot simply be combined to create corporate mens rea.
- The Supreme Court has formulated a three-stage attribution framework.
- The first stage examines corporate constitutional documents and company-law rules.
- The second stage examines express or implied delegation and the degree of discretion and independence.
- The third stage considers whether a special attribution rule is required by statutory purpose.
- Non-identification or non-arraignment of a natural person alone does not require quashing under Section 482 CrPC.
- The prosecution must nevertheless disclose, at least prima facie, corporate conduct connected with the offence and circumstances supporting the possibility of mens rea.
Frequently Asked Questions
1. Can a company be prosecuted for an offence requiring mens rea in India?
Yes. The Supreme Court has reaffirmed that corporations can face criminal prosecution for offences requiring mens rea. The crucial question is not whether a company can possess mens rea in law, but how the mental state of a natural person can be attributed to the corporation.
2. Does a company employee have to be named as an accused before the company can be prosecuted?
Not necessarily. In Sanofi India Ltd. v. CBI, the Supreme Court held that identification and arraignment of a natural person are not, by themselves, prerequisites for maintaining corporate prosecution at the Section 482 CrPC stage.
3. What is the new corporate attribution framework laid down by the Supreme Court?
The framework has three stages: first, examine corporate constitutional documents and company-law rules; second, examine express or implied delegation of authority; and third, where necessary, determine whether statutory purpose requires a special attribution rule and whether the person falls within it.
4. What is corporate mens rea?
Corporate mens rea is the legally attributed guilty mind of a natural person that becomes the mental state of the corporation. The Supreme Court held that corporate mens rea cannot be created by simply combining fragments of different individuals’ mental states.
5. Is the “directing mind and will” doctrine still relevant?
Yes, but it is not a standalone status-based test. The Supreme Court’s framework looks at authority, delegation, corporate structure and statutory purpose rather than automatically treating a director or senior officer’s status as sufficient for attribution.
6. What did the Supreme Court say about Section 482 CrPC?
Section 482 jurisdiction remains exceptional and must be exercised cautiously. At the threshold, the court generally asks whether the allegations, taken at face value, disclose an offence. It should not conduct a mini-trial or assess the eventual sufficiency of evidence.
7. Does Aneeta Hada require a natural person to be arraigned before a company can be prosecuted?
No. The Supreme Court explained that Aneeta Hada concerned statutory vicarious liability under Section 141 of the Negotiable Instruments Act. It does not establish a general rule that a natural person must always be arraigned before corporate prosecution is maintainable.
8. Can corporate criminal proceedings still be quashed under Section 482 CrPC?
Yes. Sanofi India does not eliminate Section 482 jurisdiction in corporate cases. Proceedings may still be quashed where the allegations do not disclose an offence or are merely bald and unsupported. The absence of a named natural person, standing alone, is insufficient.
9. Must the natural person whose mens rea is attributed be a director?
No. The Court deliberately framed its analysis in terms of natural persons generally, rather than limiting attribution to directors or persons formally in charge of corporate affairs.
10. Is the Supreme Court’s ruling on identification and arraignment applicable at every stage of a criminal case?
No such broad proposition was decided. The Court expressly stated that its analysis of identification and arraignment was confined to the exercise of Section 482 CrPC jurisdiction. It left open whether identification or arraignment may be necessary at a later stage and, if so, when.
11. What must allegations against a company show at the Section 482 stage?
At minimum, they should prima facie show that natural persons acted on behalf of the corporation, that the acts are referable to the alleged offence, and that the surrounding circumstances do not make the required mens rea inherently improbable.
12. Why is Sanofi India Ltd. v. CBI important?
The judgment fills an important doctrinal gap in Indian corporate criminal law. It confirms corporate liability for mens rea offences while providing a structured three-stage framework for attributing a natural person’s mental state to a corporation and clarifying that non-identification alone does not justify threshold quashing.
Conclusion
Sanofi India Ltd. v. Central Bureau of Investigation is an important Supreme Court judgment on the evolving law of corporate criminal liability in India.
Its central contribution is the distinction between the existence of corporate mens rea and the method of attributing mens rea to a corporation. While earlier decisions had established that companies could be criminally liable for offences requiring a guilty mind, Sanofi India provides a structured attribution framework to determine when a natural person’s state of mind can legally become the corporation’s state of mind.
The judgment also strikes a balance at the Section 482 stage. A company cannot demand automatic quashing merely because the individual through whom the alleged conduct occurred has not been identified or arraigned. At the same time, the prosecution must cross a meaningful threshold: the allegations must disclose corporate involvement, relevant natural-person conduct and circumstances supporting the possibility of the requisite mens rea.
The ruling therefore strengthens the conceptual foundation of corporate criminal liability without converting corporate status into automatic criminal responsibility. It also makes clear that the attribution exercise is fact-sensitive and that many difficult questions will ultimately belong to the trial rather than the threshold stage.
